In vitro and in vivo animal model studies may be at the genetic, biochemical or cell biological level. R21 and R03 applications that address HIBP guidelines will be reviewed in a Special Emphasis Panel; IDM (80) or IDM (81).

 

The List of Reviewers lists all present, whether permanent or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.

Review Dates

Membership Panel

The membership panel is a list of chartered members only.

Topics


  • Molecular basis for bacteria-host interactions including: in vivo survival and growth, intracellular replication dissemination, intercellular spread
  • Immune response of the host to bacteria, characterization of the role of immunomodulators and effector molecules in pathogenicity, manipulation and evasion of innate and adaptive immune responses
  • Interplay between bacteria and host cell components and processes, subversion and manipulation of normal host cell processes
  • Mechanisms of asymptomatic colonization and the balance between infection and disease, and commensalism and pathogenicity
  • Animal models of infection and disease, including host genetic determinants of susceptibility and resistance and surrogate hosts

Overlaps with Closely Related Study Sections

There are shared interests with Bacterial Pathogenesis (BACP) in the investigations of the process of bacterial infections. R01 grant applications that focus on the bacterial side of the host-pathogen relationship may be reviewed in BACP. Applications that focus on the host side of the host-pathogen relationship may be reviewed in HIBP.

There are shared interests with Oral, Dental and Craniofacial Sciences Study Section (ODCS) in the investigations of the process of bacterial infections. Grant applications that focus on studies related to oral microbiology may be reviewed in ODCS. Applications that focus on general pathogenesis issues associated with bacterial infections may be reviewed in HIBP.

There are shared interests with Drug Discovery and Mechanisms of Antimicrobial Resistance (DDR) in the investigations of the process of bacterial infections. Grant applications that focus on antimicrobial resistance mechanisms and drug discovery studies for bacterial pathogens may be reviewed in DDR. Applications that focus on general pathogenesis issues associated with bacterial infections may be reviewed in HIBP.

There are shared interests with Clinical Research and Field Studies of Infectious Diseases (CRFS) in the investigations of the process of bacterial infections. Grant applications that focus on epidemiology, diagnostics, emergence, spread and control of bacterial pathogens in the context of human infections may be reviewed in CRFS. Applications that focus on general pathogenesis issues associated with bacterial infections may be reviewed in HIBP.

There are shared interests with Immunity and Host Defense Study Section (IHD) in the investigations of the process of bacterial infections. Grant applications that focus on the understanding of the innate and adaptive immune responses to infectious agents that include mechanisms of immune responses and animal models may be reviewed in IHD. Applications that focus on the bacterial pathogenesis process, including elements of host defense, may be reviewed in HIBP.

There are shared interests with Vaccines against Microbial Diseases (VMD) in the process of bacterial infections. Grant applications that explore a late stage of vaccine development against bacteria may be reviewed in VMD. Applications that address early stage vaccine issues such as developing vaccine candidates or exploring molecular levels of bacterial pathogenesis may be reviewed in HIBP.